SCIENTIFIC BACKGROUND

G6PD

Favism (from Latin: faba = bean) is an X-linked recessive inherited metabolic disease caused by a glucose-6-phosphate dehydrogenase (G6PD) deficiency. The enzyme glucose-6-phosphate dehydrogenase plays a key role in the pentose phosphate pathway and catalyzes the conversion of glucose-6-phosphate to D-glucono-1,5-lactono-6-phosphate. This produces reduction equivalents such as NADPH that protect certain cell structures (e.g., erythrocyte membranes) from oxidative damage. The cell loses this protective mechanism due to the G6PD enzyme deficiency and hemolytic anemia occurs.

 

Various pathogenic variants in the G6PD gene lead to G6PD deficiency. The residual enzymatic activity and thus the symptom expression varies depending on the variant. G6PD deficiency is divided into different classes according to the enzyme activity measured.

 

Due to the X-linked chromosomal inheritance, it is mainly men who are affected. Hemizygous men and homozygous or combined heterozygous women with variants on the X chromosome show the fully developed phenotype. Heterozygous female carriers usually show symptoms only if there is a preferential expression of the allele in question, e.g., due to delayed X-inactivation. The prevalence is 0.14-0.37% among the German population, and 3-35% in some countries of the Mediterranean, Africa and Asia. In the Western European population, the Mediterranean form caused by variant c.563C>T [p.(Ser188Phe)] is the most common cause of favism, and it leads to a severe form of the disease (WHO class II). Drugs with an oxidative effect can trigger hemolytic-anemic crises and should only be prescribed after a thorough risk-benefit analysis. Fava bean proteins (aglycones) and its pollen also trigger hemolytic events.

 

References

Belfield and Tichy 2018, Am J Health Syst Pharm 75:97 / Minucci et al. 2009, IUBMB Life, 61: 27 / Turan 2006, Archives of Medical Research 37:880 / Beutler and Vulliamy 2002, Blood Cells Mol Dis 28:93 / Vulliamy et al. 1988, Proc Nat Acad Sci 85:571 / www.favismus.de

GENES

G6PD

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati...

Read more

Cardiovascular diseases affect the heart and blood vessels and are a leading cause of illness and death. Some are hereditary, and genetic testing can...

Read more

A recent study tracked molecular changes in 108 people over time, revealing that aging involves critical shifts around ages 44 and 60. These changes ...

Read more

In May 2024, the American Society of Clinical Oncology (ASCO) published new guidelines for germline genetic testing in patients with cancer (1). ...

Read more

Genetics as we know and understand it today has been shaped, over decades, by the work of many dedicated scientists around the world, and they all de...

Read more

A comprehensive single-cell transcriptomic atlas of 1.3 million cells from aged human brains reveals cellular pathways linked to Alzheimer’s diseas...

Read more

Infertility is a struggle for many individuals nowadays. According to the World Health Organization (WHO), 1 in 6 people experience infertility, show...

Read more

A recent study highlights promising outcomes for BRCA variant carriers with breast cancer undergoing breast-conserving therapy. Analyzing 172 women, ...

Read more

Epidermolysis bullosa (EB), sometimes called butterfly skin, is a group of rare skin diseases with a common symptom: fragile skin that tears and blis...

Read more

In the rapidly evolving field of human genetics diagnostics, laboratories face the challenge of keeping up with the latest advancements in technology...

Read more